Request Brochure

Covid 19 – We are fully operational during this time, taking calls 8am-8pm 7 days a week.

Children with leukaemia to receive CAR-T therapy on the NHS


Fantastic news today as children with leukaemia will be able to access CAR-T therapy on the NHS. The CAR-T cells in this pilot have been derived from peripheral blood. Groups are working on the same process using CAR-T cells from umbilical cord blood, a non-invasive source of therapeutic cells. Biovault Techincal’s, Shaun Mansfield, a stem cell scientist specialising in umbilical cord cells says: “We’re delighted at this step forward in cell-based therapies.”
stem cell preservation

BSc (Hons) Microbiology

Chief Executive Officer | Biovault Family

Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.


Share This Article:


Categories:


Tags:

Request a Brochure

Find out more.

Our hope is that the information in this brochure will empower you as you weigh-up your cord blood and tissue storage options and prepare for your family’s healthy future.

Download your free guide to Biovault Family's cord blood banking!